1. [P1–043]: ELENBECESTAT, A NOVEL ORAL BACE INHIBITOR, HAS NO CLINICALLY MEANINGFUL EFFECT ON QTC INTERVAL UP TO A SUPRATHERAPEUTIC DOSE OF 200 MG. (1st July 2017) Authors: Lai, Robert YK.; Darpo, Borje; Dayal, Satish; Hall, Nancy; Chang, Min‐Kun; Albala, Bruce; Ferry, Jim; Rege, Bhaskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P2–003]: ELENBECESTAT PHARMACOKINETIC DRUG‐DRUG INTERACTIONS INDICATED NO DOSAGE ADJUSTMENTS REQUIRED FOR MOST CONCOMITANT TREATMENTS. (1st July 2017) Authors: Albala, Bruce; Lai, Robert YK.; Aluri, Jagadeesh; Boyd, Peter; Chang, Min‐Kun; Dayal, Satish; Ferry, Jim; Rege, Bhaskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of alcohol coadministration on the pharmacodynamics, pharmacokinetics, and safety of lemborexant: A randomized, placebo-controlled crossover study. (June 2022) Authors: Landry, Ishani; Hall, Nancy; Aluri, Jagadeesh; Filippov, Gleb; Setnik, Beatrice; Dayal, Satish; Reyderman, Larisa; Moline, Margaret Journal: Journal of psychopharmacology Issue: Volume 36:Number 6(2022) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant. Issue 6 (2nd November 2020) Authors: Landry, Ishani; Aluri, Jagadeesh; Hall, Nancy; Kumar, Dinesh; Dayal, Satish; Moline, Margaret; Reyderman, Larisa Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 6(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant. Issue 2 (6th April 2021) Authors: Dayal, Satish; Aluri, Jagadeesh; Hall, Nancy; Filippov, Gleb; Moline, Margaret; Reyderman, Larisa; Landry, Ishani Journal: Pharmacology research & perspectives Issue: Volume 9:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant. Issue 2 (10th March 2021) Authors: Landry, Ishani; Aluri, Jagadeesh; Hall, Nancy; Filippov, Gleb; Dayal, Satish; Moline, Margaret; Reyderman, Larisa Journal: Pharmacology research & perspectives Issue: Volume 9:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females. Issue 9 (9th June 2021) Authors: Landry, Ishani; Aluri, Jagadeesh; Hall, Nancy; Filippov, Gleb; Dayal, Satish; Moline, Margaret; Reyderman, Larisa Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 9(2021) Page Start: 1089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant. Issue 6 (17th January 2021) Authors: Landry, Ishani; Aluri, Jagadeesh; Nakai, Kenya; Hall, Nancy; Miyajima, Yukiko; Ueno, Takashi; Dayal, Satish; Filippov, Gleb; Lalovic, Bojan; Moline, Margaret; Reyderman, Larisa Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 6(2021) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers. Issue 1 (17th June 2020) Authors: Hong, David S; Parikh, Aparna; Shapiro, Geoffrey I; Varga, Andrea; Naing, Aung; Meric-Bernstam, Funda; Ataman, Özlem; Reyderman, Larisa; Binder, Terri A; Ren, Min; Liu, Mingjie; Dayal, Satish; Siu, Amy Y; Sachdev, Pallavi; Xu, Lucy; Bhagawati-Prasad, Vijay; Tchakov, Ilian; Ooi, Chean Eng; Bao, Xi... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 1. Issue 7 (11th April 2014) Authors: Tran, Thien Duc; Wakenhut, Florian; Pickford, Chris; Shaw, Stephen; Westby, Mike; Smith‐Burchnell, Caroline; Watson, Lesa; Paradowski, Michael; Milbank, Jared; Brimage, Rebecca A.; Halstead, Rebecca; Glen, Rebecca; Wilson, Craig P.; Adam, Fiona; Hay, Duncan; Chiva, Jean‐Yves; Nichols, Carly; Blak... Journal: ChemMedChem Issue: Volume 9:Issue 7(2014:Jul.) Page Start: 1378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗